The SAFE Sunscreen Standards Act modifies how the FDA evaluates sunscreen and other topical over-the-counter drugs to speed up the approval process and reduce reliance on animal testing. Specifically, the bill allows the FDA to consider real-world evidence alongside traditional clinical trials when determining whether sunscreen ingredients are safe and effective, and requires the agency to issue guidance within one year on alternative testing methods that don't involve animals. The legislation directs the FDA to account for historical safety data and the proven skin cancer prevention benefits of broad-spectrum sunscreens when finalizing rules on sunscreen ingredients. To ensure accountability, the bill requires the FDA to report to Congress every 18 months for six years on how these new standards are being implemented and what progress has been made in reducing animal testing. This bill primarily affects sunscreen manufacturers and consumers seeking access to effective sun protection products, though the regulatory changes apply more broadly to topical over-the-counter drugs.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.